031sek
-2,4 %
Date:2025-09-10Time:17:29:48Latest report:Q2-2025List:First NorthTicker:ACARIX
Market Cap:348 msekEnterprise Value:316 msekNet Sales:5,56 msekEarnings:-61,6 msekEmployees:0ISIN:SE0009268717

Ratios

10-year key figure history for Acarix turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Acarix with index and moving average MA50 and MA200.

Stockprice:0,31
MA50:0,36
MA200:0,28
Price/MA200:12,7 %
RSI (14):47,7
Price/MA50:-13,7 %

Description

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Medical Equipment